IL2 and tuberculosis: In the current study, we found that adjunctive ZOL/IL-2 administrations during TB drug treatment of MDR-Mtb-infected macaques led to significantly lower levels of MDR-TB bacterial burdens than adjunctive IL-2, TB drugs alone, and saline controls, respectively, with favourable clinical outcomes as body weights gains.